Anefer 100 mg/5 ml (IV Injection or Infusion)

5 ml ampoule: ৳ 327.26

Medicine Details

Treatment of Anefer deficiency in various clinical conditions
Indicated for patients with inflammatory bowel disease
Suitable for patients with chronic kidney disease
Recommended for patients undergoing surgical procedures or donating blood
Intravenously administered haematinic for rapid Anefer supply
Contains approximately 30% Sucrose w/v (300 mg/ml)
Has a pH of 10.5-11.1
Dissociates into Iron and Sucrose in the body
Iron distributes mainly in blood, liver, spleen, and bone marrow
Sucrose component is eliminated mainly through urinary excretion
Dosage varies for adults, elderly, and children
Recommended routes of administration include intravenous injection and infusion
Not to be administered concomitantly with oral iron preparations
Contraindicated in patients with evidence of Iron overload or known hypersensitivity to Iron Sucrose
Potential adverse reactions include hypotension, nausea, vomiting, headache, and hypersensitivity reactions
Categorized as Pregnancy Category-B with caution advised during lactation
Periodic monitoring of hematologic and haematinic parameters is required for patients receiving Anefer
Safety and effectiveness in pediatric patients have not been established
Avoid administration in the presence of evidence of tissue Anefer overload
Storage instructions: Cool (15°C-30°C) & dry place, protected from light; do not freeze